Skip to main content
رجوع
ORKA logo

Oruka Therapeutics, Inc.

جودة البيانات: 100%
ORKA
NASDAQ Healthcare Biotechnology
KWD 41.56
▲ KWD 2.65 (6.81%)
القيمة السوقية: 1.56B
نطاق اليوم
KWD 39.17 KWD 41.67
نطاق 52 أسبوعًا
KWD 5.49 KWD 42.88
حجم التداول
550,931
متوسط 50 يوم / 200 يوم
KWD 34.01 / KWD 23.79
الإغلاق السابق
KWD 38.91

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -14.8 0.4
P/B 3.3 2.9
ROE % -24.7 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.0 0.2

النقاط الرئيسية

Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -88.42M
PEG of 0.24 suggests growth is underpriced

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-24.69%
ROIC-19.32%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.00
Current Ratio22.37
Interest Coverage0.00

التقييم

P/E Ratio
-14.76
P/B Ratio3.30
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -105.43M
ROE -24.69% ROA -21.58%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -88.42M
ROIC -19.32% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 22.37
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -14.76 P/B Ratio 3.30
P/S Ratio N/A PEG Ratio 0.24
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.56B Enterprise Value 1.51B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -105.43M -83.72M -5.34M -9.93M -19.32M
EPS (Diluted) -2.31 -4.99 -4.44 -8.27 -16.68
Gross Profit -83,000.0 -27,000.0 -111,000.0 -114,000.0 -91,000.0
Operating Income -122.05M -88.12M -7.30M -9.84M -19.34M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 488.62M 396.02M 37.86M 43.09M 54.92M
Total Liabilities 16.69M 13.80M 841,000.0 1.41M 3.88M
Shareholders' Equity 471.93M 382.22M 37.02M 41.67M 51.04M
Total Debt 1.93M 968,000.0 280,000.0 383,000.0 483,000.0
Cash & Equivalents 46.94M 61.58M 37.43M 42.45M 53.36M
Current Assets 343.86M 376.87M 37.59M 42.70M 54.42M
Current Liabilities 15.37M 13.04M 637,000.0 1.13M 3.50M